Search Result "Janus kinase inhibitors"


Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis

Journal: Current Rheumatology Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 306-312
Author(s): Kunihiro Yamaoka, Yoshiya Tanaka

Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors

Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1767-1784
Author(s): M. Cetkovic-Cvrlje, H. E. Tibbles

Review Article

The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer

Journal: Current Cancer Drug Targets
Volume: 22 Issue: 3 Year: 2022 Page: 221-233
Author(s): Kakasaheb Ramoo Mahadik

Review Article

Current Status in the Discovery of Covalent Janus Kinase 3 (JAK3) Inhibitors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 1 Year: 2019 Page: 1531-1543
Author(s): Jun Dai,LiXi Yang,Glynn Addison

Review Article

Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 1 Year: 2019 Page: 2823-2843
Author(s): Felice Rivellese,Antonio Lobasso,Letizia Barbieri,Bianca Liccardo,Amato de Paulis,Francesca Wanda Rossi

Review Article

Targeting Janus Kinase (JAK) for Fighting Diseases: The Research ofJAK Inhibitor Drugs

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 2 Year: 2022 Page: 5010-5040
Author(s):

Review Article

Interleukin Receptor Antagonists and Janus Kinase Inhibitors Repurposedfor Treatment of COVID-19

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 21 Year: 2022 Page: 2752-2768
Author(s):

Review Article

Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology

Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1158-1167
Author(s): Kresimir Kostovic,Sandra J. Gulin,Zrinka B. Mokos,Romana Ceovic

Review Article

Application of Kinase Inhibitors for Anti-aging Intervention

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4351-4368
Author(s): Mercedes Cano,Antonio Ayala,Francesco Marotta,Sandro Arguelles

Perspective

Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitorfor the Treatment of Atopic Dermatitis

Journal: Current Medicinal Chemistry
Volume: 30 Issue: 38 Year: 2023 Page: 4278-4282
Author(s): Surya K. De

Previous   Next

Go To   Results 1 - 1 of 1402

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy